Business ❯ Biotechnology

Research and Development

Clinical Trials mRNA Technology Innovation Collaboration Investment Pharmaceuticals Innovation Management Wound Care Vaccine Development Drug Discovery Laboratory Facilities Funding Commercial Applications Artificial Intelligence Oncology Ophthalmology Stem Cell Technology Monoclonal Antibodies Public Relations Conservation Technology

OrbiMed Sells 860,123 Enliven Shares in Roughly $39 Million Transaction

A partial reduction that leaves OrbiMed holding roughly 6.6 million shares could shift investor views of Enliven's Phase 1 drug pipeline.

Rice Scientists Publish CLASSIC to Massively Expand DNA Circuit Design and Testing

Nature Cell to Build 100,000-Square-Foot Stem Cell Plant in West Baltimore, Adding 500 Jobs

Cidara Gains on JP Morgan Coverage Initiation as ESWI Presentation Nears

Amgen Commits Over $600 Million to New R&D Center at Thousand Oaks Headquarters

Colossal Biosciences Unveils First Pack Encounters of Engineered Dire Wolves